| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $1.87B | +34.8% |
| Cost of Revenue | $947.0M | +29.5% |
| Gross Profit | $922.0M | +40.8% |
| R&D Expense | $789.0M | +45.0% |
| SG&A Expense | $50.0M | +47.1% |
| Operating Income | -$37.0M | +35.1% |
| Pre-tax Income | -$32.0M | +43.9% |
| Income Tax | $50.0M | +177.8% |
| Net Income | -$82.0M |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $1.02B | +66.2% |
| Accounts Receivable | $269.0M | +73.5% |
| Inventory | $113.0M | +16.5% |
| Current Assets | $1.52B | -33.2% |
| Total Assets | $15.44B | -7.3% |
| Current Liabilities | $384.0M | -19.0% |
| Total Liabilities | $647.0M | -15.5% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $546.0M | -8.8% |
| Capital Expenditures | $111.0M | -22.4% |
| Investing Cash Flow | $1.19B | +856.1% |
| Financing Cash Flow | -$1.32B | -1547.3% |
| Free Cash Flow | $435.0M | -4.6% |
| -9.3% |
| EPS (Basic) | -$0.11 | -10.0% |
| EPS (Diluted) | -$0.11 | -10.0% |
| Stockholders' Equity |
| $14.79B |
| -6.9% |